← Oncology Approval Tracker

FDA DECISION ·

Ibrutinib (generic Imbruvica)

ibrutinib · Zydus Worldwide

First generic approvalFirst genericB-cell malignancies
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic Imbruvica capsules for the original labeled adult uses, including mantle cell lymphoma, CLL or SLL, Waldenström macroglobulinemia, marginal zone lymphoma and chronic graft-versus-host disease.

LAMPGEN ANALYSIS

Why it matters

This records the first ANDA action for ibrutinib capsules. Individual disease indications have distinct regulatory histories.

What research teams should watch

Use the historical ANDA label by indication, and record market availability separately from the approval date.

PRIMARY RECORDS

Sources